Related references
Note: Only part of the references are listed.Effects of disease-modifying therapy on peripheral leukocytes in patients with multiple sclerosis
F. Schweitzer et al.
JOURNAL OF NEUROLOGY (2021)
Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets
Maria Hjorth et al.
PLOS ONE (2020)
Event-Driven Immunoprofiling Predicts Return of Disease Activity in Alemtuzumab-Treated Multiple Sclerosis
Katja Akguen et al.
FRONTIERS IN IMMUNOLOGY (2020)
The role of TH17 cells in multiple sclerosis: Therapeutic implications
Tobias Moser et al.
AUTOIMMUNITY REVIEWS (2020)
Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only
S. Kalra et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2020)
Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis
Giancarlo Comi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Potential mechanisms of action related to the efficacy and safety of cladribine
David Baker et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Alemtuzumab in Multiple Sclerosis: Short- and Long-Term Effects of Immunodepletion on the Peripheral Treg Compartment
Juergen Haas et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune reconstitution therapies: concepts for durable remission in multiple sclerosis
Jan D. Lünemann et al.
Nature Reviews Neurology (2019)
Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study
Konrad Rejdak et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Effects of cladribine tablets on lymphocyte subsets in patients with multiple sclerosis: an extended analysis of surface markers
Olaf Stuve et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Safety and efficacy of cladribine tablets in patients with relapsing-remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study
Gavin Giovannoni et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention
Jamie van Langelaar et al.
BRAIN (2018)
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie et al.
JOURNAL OF NEUROLOGY (2018)
Interpreting Lymphocyte Reconstitution Data From the Pivotal Phase 3 Trials of Alemtuzumab
David Baker et al.
JAMA NEUROLOGY (2017)
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
David Baker et al.
EBIOMEDICINE (2017)
CCR6+ Th cells in the cerebrospinal fluid of persons with multiple sclerosis are dominated by pathogenic non-classic Th1 cells and GM-CSF-only-secreting Th cells
S. M. Restorick et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS
Katja Thomas et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2016)
Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis
Thomas P. Leist et al.
CLINICAL NEUROPHARMACOLOGY (2011)
Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity
Bruno Laugel et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
Sara A. J. Thompson et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling et al.
NEUROLOGY (2010)
Preferential Recruitment of Interferon-γ-Expressing TH17 Cells in Multiple Sclerosis
Hania Kebir et al.
ANNALS OF NEUROLOGY (2009)
Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis
John S. Tzartos et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Autoimmunity during lymphopenia: A two-hit model
Tom Krupica et al.
CLINICAL IMMUNOLOGY (2006)
Expression of CCR7 in multiple sclerosis:: Implications for CNS immunity
P Kivisäkk et al.
ANNALS OF NEUROLOGY (2004)
Effects of cryopreservation on lymphocyte immunophenotype and function
A Costantini et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Share Paper
